TABLE 3.

Association Between Opioid Misuse and Factors That Influence Risk of HIV Transmission Among Adults Receiving HIV Medical Care MMP, 2009–2014 (N = 28,162)

	Misused Opioids (n = 975)		Did Not Misuse Opioids (n = 27,187)
	n*	% (95% CI)†	n*	% (95% CI)†	P for Rao-Scott χ2 Test
Condomless sex with partner of negative or unknown HIV status while not durably virally suppressed‡
Yes	100	11.7 (9.2 to 14.1)	900	3.4 (3.1 to 3.6)	<0.0001
Distributive syringe sharing§║
Yes	37	16.6 (10.8 to 22.4)	31	9.3 (5.4 to 13.2)	0.0245
Distributive sharing of other injection equipment (eg, cookers, cotton, or rinse water)§
Yes	54	21.2 (14.0 to 28.3)	22	6.6 (3.6 to 9.6)	<0.0001
Division of shared drugs with a syringe§
Yes	75	30.9 (23.3 to 38.5)	77	18.9 (14.6 to 23.3)	0.0037
Received HIV or STD prevention counseling by an outreach worker, counselor, or prevention program worker
Yes	405	38.3 (33.5 to 43.1)	8829	31.6 (29.1 to 34.0)	0.0002
Received HIV or STD prevention counseling by a health care provider
Yes	522	50.7 (46.7 to 54.6)	13,028	47.0 (44.3 to 49.7)	0.0578

^*Numbers are unweighted.

^†Percentages and corresponding CIs are weighted percentages.

^‡All viral load measurements documented undetectable or <200 copies/mL during the past 12 months.

^§Among respondents who injected opioids vs those who injected other drugs.

^║Respondent gave their used needle to someone else for use.